MDT Medtronic Plc

93.241.60 (+1.75%)
IEX real time price: 10:15:46 AM

Quote

Previous Close
$91.64
Day Range
$92.01-$93.92
52 Week Range
$81.66-$100.15
Volume
1,899,890
Avg Volume
5,793,621
Dividend TTM
$1.96 (2.14%)
Ex-Dividend Date
2019-03-21

Valuation

Market Cap
$125.05B
Enterprise Value (EV)
$133.57B
PE Ratio
25.55
EV/EBITDA
13.92
Price/Sales
3.97
Price/Book
2.42
PEG Ratio
2.97

Financials

Revenue
$29.95B
Gross Profit
$19.14B
EBITDA
$9.60B
EPS, ttm
$3.65
Profit Margin
10.36%
Revenue/Employee
$346.81K
Next Earnings Date
8/20/2019 (88 days)
Debt to Equity
51%
Debt
$19.75B
Cash
$11.23B
Net Debt
$8.52B

Performance

Beta
0.68
200 Day Moving Avg
$91.53
50 Day Moving Avg
$88.83
52 Week Change
5.35%
YTD Change
5.98%
1 Month Change
7.01%
3 Month Change
-0.63%
6 Month Change
-0.46%
1 Year Change
5.35%
2 Year Change
8.22%
5 Year Change
51.97%

Share Count

Shares Outstanding
1.3B
Float
1.3B
Restricted Shares
1.9M
Restricted Shares, %
0.14%

Medtronic Plc Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Omar S. Ishrak

Website: http://www.medtronic.com

Description: Medtronic Plc is a medical technology company, which develop, manufacture, distribute, and sell device-based medical therapies and services. It also provides services to the hospitals, physicians, clinicians, and patients. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist of three divisions: Cardiac Rhythm & Heart Failure, Coronary & Structural Heart, and Aortic & Peripheral Vascular. The Minimally Invasive Technologies Group segment comprises of three divisions: Surgical Innovations and Respiratory, Gastrointestinal, and Renal. The Restorative Therapies Group contains four divisions: Spine, Brain, Specialty Therapies, and Pain Therapies. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Employees: 86,368